Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior

被引:161
作者
Borowsky, AD
Namba, R
Young, LJT
Hunter, KW
Hodgson, JG
Tepper, CG
McGoldrick, ET
Muller, WJ
Cardiff, R
Gregg, JP
机构
[1] Univ Calif Davis, Dept Comparat Med, Ctr Comparat Med, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA
[3] NCI, Lab Populat Genet, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[5] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA
[6] McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada
关键词
Akt; breast; breast carcinoma; cell line metastasis; comparative genomic hybridization; ERBB2; gene expression analysis; LY294002; mammary fat pad; mouse mammary tumor virus long terminal repeat; oncogene; orthotopic; phosphatidylinositol; 3; kinase; polyoma middle T; pulmonary metastasis; Sept9; Spp1; osteopontin; Opn; syngeneic; transgenic; tumor transplant;
D O I
10.1007/s10585-005-2908-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two cell lines, Met-1(fvb2) and DB-7(fvb2), with different metastatic potential, were derived from mammary carcinomas in FVB/N-Tg(MMTV-PyVmT) and FVB/N-Tg(MMTV-PyVmT(Y315F/Y322F)) mice, transplanted into syngeneic FVB/N hosts and characterized. The lines maintain a stable morphological and biological phenotype after multiple rounds of in vitro culture and in vivo transplantation. The Met-1(fvb2) line derived from a FVB/N-Tg(MMTV-PyVmT) tumor exhibits invasive growth and 100% metastases when transplanted into the females FVB/N mammary fat pad. The DB-7(fvb2) line derived from the FVB/N-Tg(MMTV-PyVmT(Y315F/Y322F)) with a "double base" modification at Y315F/Y322F exhibits more rapid growth when transplanted into the mammary fat pad, but a lower rate of metastasis (17%). The Met1(fvb2) cells show high activation of AKT, while DB-7(fvb2) cells show very low levels of AKT activation. The DNA content and gene expression levels of both cell lines are stable over multiple generations. Therefore, these two cell lines provide a stable, reproducible resource for the study of metastasis modulators, AKT molecular pathway interactions, and gene target and marker discovery.
引用
收藏
页码:47 / 58
页数:12
相关论文
共 38 条
  • [11] INDUCTION OF MAMMARY-TUMORS BY EXPRESSION OF POLYOMAVIRUS MIDDLE T-ONCOGENE - A TRANSGENIC MOUSE MODEL FOR METASTATIC DISEASE
    GUY, CT
    CARDIFF, RD
    MULLER, WJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (03) : 954 - 961
  • [12] Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas
    Hager, JH
    Hodgson, JG
    Fridlyand, J
    Hariono, S
    Gray, JW
    Hanahan, D
    [J]. CANCER RESEARCH, 2004, 64 (07) : 2406 - 2410
  • [13] Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas
    Hodgson G.
    Hager J.H.
    Volik S.
    Hariono S.
    Wernick M.
    Moore D.
    Albertson D.G.
    Pinkel D.
    Collins C.
    Hanahan D.
    Gray J.W.
    [J]. Nature Genetics, 2001, 29 (4) : 459 - 464
  • [14] Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
    Hutchinson, J
    Jin, J
    Cardiff, RD
    Woodgett, JR
    Muller, WJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (06) : 2203 - 2212
  • [15] Cancer statistics, 2004
    Jemal, A
    Tiwari, RC
    Murray, T
    Ghafoor, A
    Samuels, A
    Ward, E
    Feuer, EJ
    Thun, MJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) : 8 - 29
  • [16] Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin
    Jessen, KA
    Liu, SY
    Tepper, CG
    Karrim, J
    McGoldrick, ET
    Rosner, A
    Munn, RJ
    Young, LJT
    Borowsky, AD
    Cardiff, RD
    Gregg, JP
    [J]. BREAST CANCER RESEARCH, 2004, 6 (03): : R157 - R169
  • [17] What is the optimal rodent model for anti-tumor drug testing?
    Kerbel, RS
    [J]. CANCER AND METASTASIS REVIEWS, 1998, 17 (03) : 301 - 304
  • [18] KHANNA C, 2004, MODELING METASTASIS
  • [19] Paclitaxel (Taxol): An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer
    Lau, DH
    Xue, L
    Young, LJ
    Burke, PA
    Cheung, AT
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1999, 14 (01) : 31 - 36
  • [20] An epistatic interaction controls the latency of a transgene-induced mammary tumor
    Le Voyer, T
    Lu, ZC
    Babb, J
    Lifsted, T
    Williams, M
    Hunter, K
    [J]. MAMMALIAN GENOME, 2000, 11 (10) : 883 - 889